Mon, December 8, 2008
Sun, December 7, 2008
Sat, December 6, 2008
Fri, December 5, 2008
Thu, December 4, 2008
Wed, December 3, 2008
[ Wed, Dec 03rd 2008 ] - Market Wire
Protherics PLC: Offer Update
Tue, December 2, 2008
Mon, December 1, 2008
Sun, November 30, 2008
Fri, November 28, 2008
Thu, November 27, 2008
Wed, November 26, 2008
Tue, November 25, 2008
[ Tue, Nov 25th 2008 ] - Market Wire
HST Global Quarterly Update
Mon, November 24, 2008
Thu, November 20, 2008
Wed, November 19, 2008
Tue, November 18, 2008
Mon, November 17, 2008

Optimer Pharmaceuticals to Present at the 20th Annual Piper Jaffray Health Care Conference


//health-fitness.news-articles.net/content/2008/ .. annual-piper-jaffray-health-care-conference.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


SAN DIEGO, CA--([ BUSINESS WIRE ])--Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) is scheduled to present at the 20th Annual Piper Jaffray Health Care Conference at The New York Palace in New York City on December 2, 2008, 12:00 p.m. Eastern Time.

A live audio webcast of this presentation will be accessible on the Company's website at [ www.optimerpharma.com ], under the investors section. A replay of this presentation will be available at the same location for thirty days following the meeting.

About Optimer Pharmaceuticals

Optimer Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing innovative anti-infective products to treat serious infections and address unmet medical needs. Optimer has two late-stage anti-infective product candidates under development. OPT-80 is the only antibiotic therapy currently under Phase 3 worldwide development for Clostridium difficile infection. Prulifloxacin is an antibiotic being developed for the treatment of travelers' diarrhea, a form of infectious diarrhea. Additional information can be found at http://[ www.optimerpharma.com ].


Publication Contributing Sources

Similar Health and Fitness Publications